Zusammenfassung
Die Diagnostik des Prostatakarzinoms stützt sich auf 3 Untersuchungsparameter: die digitale rektale Untersuchung (DRU), den transrektalen Ultraschall (TRUS) und die Bestimmung des prostataspezifischen Antigens (PSA) im Serum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Breul J et al. (1991) Fehler bei der präoperativen Bestimmung des lokalen Tumorstadiums bei der radikalen Prostatektomie. In: Hartung, Hübner, Kropp (eds) Urologische Beckenchirurgie. Springer, Berlin Heidelberg New York Tokio.
Chybrowski F et al. (1991) Predicting radionuclid bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters. J Urol 145:313.
Cooper EH, Purves D (1994) Bone alkaline phosphatase and prostate specific antigen in the monitoring of prostate cancer. Prostate 25: 236–242.
Cowan RJ YK (1973) Evaluation of serum alkaline phophatase dermination in patients with positive bone scans. Cancer 32: 887–889.
DE/Editorial (1992) New biomarkers of bone resorption. J Clin Endocrin Met 74: 470A–470C.
Desoize BAS et al. (1991) Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma. Clin Biochem 24: 443–446.
Devonec M et al. (1990) The significance of the prostatic hypoechoic area: results in 226 ultrasonically guided prostatic biopsies. J Urol 143: 316–319.
Epstein J et al. (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71: 3586.
Katz A et al. (1994) Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765–775.
Kleer E, Oesterlin JE (1993) PSA and staging of localized prostate cancer. Urol Clin North Am 20: 695–705.
Kramer S et al. (1980) Experience with Gleason’s histopathologic grading in prostatic cancer. J Urol 124: 223.
Lowe F, Brendler CB (1992) Evaluation of the urological patient. In: Walsh P et al. (eds) CambelPs urology, 6th edn. Saunders, Philadelphia.
Merrick MV et al. (1985) Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol 57: 715–720.
Oeffelein M et al. (1996) Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 155: 238–242.
Oesterling J et al. (1993) The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269: 57.
Oyen R et al. (1994) Prostata, Samenblasen und Samenwege. In: Lüning M, Felix, R (Hrsg) Komplexe bildgebende Diagnostik — Becken. Thieme, Stuttgart.
Partin A et al. (1990) Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143: 747.
Rovik J et al. (1994) zzzz. Br J Urol 73: 65.
Schröder F et al. (1992) Prostate cancer — local staging with endorectal surface coil MR imaging. Radiology 178: 797–802.
Schröder F et al. (1992) The TNM classifcation of prostate cancer. Prostate S4:129–138.
Spigelman et al. (1986) Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol 136:1228–1230.
Weingärtner K et al. (1996) Anatomical basis for pelvic lamphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156:1969–1971.
Whitemore W et al. (1988) Organ systems program staging classification for prostate cancer. In: Coffey D, Resnick, MI, Dorr, FA Karr, JP (eds) A multidisciplinary analysis of controversies in the management of prostate cancer. Plenum Press, New York.
Wood D et al. (1994) Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533–2540.
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Breul, J., Paul, R. (1999). Stagingprobleme beim Prostatakarzinom aus urologischer Sicht. In: Prostatakarzinom — urologische und strahlentherapeutische Aspekte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60064-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-60064-7_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64241-8
Online ISBN: 978-3-642-60064-7
eBook Packages: Springer Book Archive